OpenAlex
PricingAboutJobs
Log inGet started
Work

A Novel Disease-Modifying Antirheumatic Drug, Iguratimod, Ameliorates Murine Arthritis by Blocking IL-17 Signaling, Distinct from Methotrexate and Leflunomide

HTML

Year: 2013
Type: article
Source: The Journal of Immunology
DOI: 10.4049/jimmunol.1300832
Authors: Qiong Luo, Yang Sun, Wen Liu, Cheng Qian, Biao Jin, Feifei Tao, Yanhong Gu, Xingxin Wu, Yan Shen, Qiang Xu
Institutions: State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Jiangsu Province Hospital, Yale University
Language: English

Topic: Rheumatoid Arthritis Research and Therapies
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: iguratimod, rheumatoid arthritis, IL-17 signaling, disease-modifying antirheumatic drugs, methotrexate, leflunomide, collagen-induced arthritis, synovitis, synovial fibroblasts, Act1, TRAF5, IKKi, MAPK phosphorylation, mRNA stability
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2144635371
FWCI: 3.022
Cites: 48
Cited by: 110
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms